Dubai Telegraph - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.240661
AFN 75.055375
ALL 91.712691
AMD 419.720863
ANG 2.067349
AOA 1060.021451
ARS 1740.139649
AUD 1.619478
AWG 2.079918
AZN 1.959843
BAM 1.957789
BBD 2.325642
BDT 142.164398
BGN 1.943883
BHD 0.435238
BIF 3452.47682
BMD 1.154708
BND 1.46938
BOB 13.33643
BRL 5.941086
BSD 1.154663
BTN 110.801583
BWP 15.627738
BYN 3.506131
BYR 22632.273853
BZD 2.322239
CAD 1.608158
CDF 2670.239636
CHF 0.944783
CLF 0.027901
CLP 1101.683802
CNY 7.749764
CNH 7.746993
COP 3607.111022
CRC 516.720364
CUC 1.154708
CUP 30.599758
CVE 110.375676
CZK 24.299695
DJF 205.617067
DKK 7.475313
DOP 67.898377
DZD 154.384613
EGP 59.959244
ERN 17.320618
ETB 185.907753
FJD 2.55531
FKP 0.85672
GBP 0.856522
GEL 3.001296
GGP 0.85672
GHS 13.261297
GIP 0.85672
GMD 84.868683
GNF 10153.224815
GTQ 8.814877
GYD 241.573277
HKD 9.057534
HNL 31.084527
HRK 7.531701
HTG 150.911976
HUF 365.231755
IDR 20432.555399
ILS 3.503617
IMP 0.85672
INR 110.753109
IQD 1513.244637
IRR 1587261.41017
ISK 139.833216
JEP 0.85672
JMD 181.861569
JOD 0.818648
JPY 179.232626
KES 149.696591
KGS 100.978968
KHR 4677.710693
KMF 493.060761
KPW 1039.237432
KRW 1580.056315
KWD 0.356297
KYD 0.962269
KZT 516.430071
LAK 25841.023227
LBP 103400.029098
LKR 380.923609
LRD 201.603025
LSL 18.787083
LTL 3.409552
LVL 0.698472
LYD 7.320632
MAD 10.917094
MDL 20.074216
MGA 5051.84629
MKD 61.588623
MMK 2424.452972
MNT 4151.261485
MOP 9.329495
MRU 46.246332
MUR 54.537163
MVR 17.782612
MWK 2005.164634
MXN 19.788407
MYR 4.670101
MZN 73.797481
NAD 18.77731
NGN 1530.415431
NIO 42.27396
NOK 10.776525
NPR 177.282533
NZD 2.007154
OMR 0.443985
PAB 1.154663
PEN 3.874038
PGK 5.129788
PHP 72.414013
PKR 320.101358
PLN 4.340789
PYG 6872.921382
QAR 4.205388
RON 5.259927
RSD 117.361067
RUB 97.22604
RWF 1696.193464
SAR 4.333705
SBD 9.279521
SCR 15.946242
SDG 694.558334
SEK 11.28179
SGD 1.470087
SHP 0.857053
SLE 28.451622
SLL 24213.636878
SOS 659.858797
SRD 43.590087
STD 23900.121142
STN 24.883954
SVC 10.103174
SYP 15013.511755
SZL 18.752618
THB 38.424637
TJS 10.651727
TMT 4.053025
TND 3.36453
TOP 2.780259
TRY 56.184391
TTD 7.835891
TWD 36.692226
TZS 3057.09247
UAH 51.54701
UGX 4537.549896
USD 1.154708
UYU 46.436764
UZS 13584.798231
VES 971.32176
VND 29994.113748
VUV 136.436829
WST 3.160128
XAF 655.957
XAG 0.017914
XAU 0.000267
XCD 3.120655
XCG 2.081032
XDR 0.816438
XOF 655.957
XPF 119.331742
YER 273.129813
ZAR 18.747086
ZMK 10393.757908
ZMW 22.544704
ZWL 371.815456
SSP 6530.200245
MXV 2.243736
  • RBGPF

    0.0000

    69.99

    0%

  • CMSD

    -0.1700

    20.07

    -0.85%

  • RYCEF

    0.2600

    19.3

    +1.35%

  • BCC

    0.6800

    75.93

    +0.9%

  • BCE

    -0.2534

    22.9

    -1.11%

  • CMSC

    -0.1000

    20.32

    -0.49%

  • VOD

    0.1500

    17.68

    +0.85%

  • RIO

    -0.3800

    97.26

    -0.39%

  • NGG

    -0.0300

    74.93

    -0.04%

  • GSK

    -0.0400

    50.01

    -0.08%

  • JRI

    -0.2065

    11.62

    -1.78%

  • BTI

    -0.7700

    56.52

    -1.36%

  • RELX

    -1.5000

    34.22

    -4.38%

  • AZN

    -1.9300

    161.85

    -1.19%

  • BP

    1.0300

    46.96

    +2.19%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

Y.El-Kaaby--DT